Learning @ ISTM
Series 1: Dengue in the Time of COVID-19: The Experience in Endemic Countries
Recorded On: 10/20/2021
- Non-Member - $70
- 5 Year Doctoral Level Member - Free!
- 5 Year Non-Doctoral Level Member - Free!
- Doctoral Level Members - Free!
- Associate Doctoral Level Members - Free!
- Retiree Doctoral Level Members - Free!
- Non-Doctoral Level Members - Free!
- Lifetime Retiree Doctoral Level Member - Free!
- Associate Non-Doctoral Level Members - Free!
- Retiree Non-Doctoral Level Members - Free!
- Lifetime Retiree Non-Doctoral Level Member - Free!
- Limited (Student/Trainee) Level Members - Free!
- Special Associate Member - Free!
- Staff/Administration - Free!
- Hon. Lifetime Member - Free!
The COVID-19 pandemic has created special challenges in countries that are highly endemic for dengue. In this Zoom webinar, our experts will highlight these challenges and bring you the latest, most up to date information. Current clinical findings, effectiveness of control measures including vector control strategies, as well as interactions between SARS-CoV-2 and dengue viruses will be examined. Our webinar will focus on Thailand and Brazil, two very popular travel destinations that are highly endemic for dengue, as these countries currently fight the spread of COVID-19.
This webinar is Series 1 of 2 of Dengue and COVID-19 focused webinars. You can find Series 2 on the webinar page of the LMS.
• What are the most common risks for dengue?
• How to advise a traveller during pre-travel screening.
• Learn typical clinical manifestations of the different forms of dengue and COVID-19, especially with variants.
• Enhanced understanding of how travellers can reduce their risk for dengue and Covid-19 and their complications.
• Recognize the current situation in countries that are highly endemic for Dengue.
* Please note that this is a Zoom webinar. To join the webinar, login to your Learning @ ISTM account and go to your dashboard. Click the webinar link in the contents tab. Google Chrome is the recommended browser for Zoom webinars.
Karin Leder, MD, MPH, PhD (Moderator)
Physician and Professor
Monash University, Royal Melbourne Hospital
Professor Karin Leder is an infectious diseases physician, Head of the Infectious Diseases Epidemiology Unit in the School of Public Health and Preventive Medicine at Monash University, and Head of Travel Medicine and Immigrant Health Services at the Victorian Infectious Disease Service, Royal Melbourne Hospital. She is a Fellow of the Royal Australasian College of Physicians, has a Masters of Public Health (Harvard University) and a PhD (Monash University, received Vice-Chancellor’s commendation for doctoral thesis excellence). She holds a NHMRC Senior Research Fellowship (2019 – 2023).
Prof Leder is involved in diverse areas of clinical and public health infectious disease research. Major foci of work include risks of infections from exposure to contaminated environments and unsafe water, factors associated with spread of infections across international borders, global surveillance of health risks associated with travel, tropical medicine, vaccination and prevention of infections, research design, and public health assessment.
Prof Leder has published over 270 research publications and book chapters. She is the Travel Medicine Section Editor and an invited co-author on 28 chapters for UpToDate, a widely used clinician's tool. She has been an invited expert the World Health Organisation’s strategies for International Travel and Health, an advisor to the Australian Academy of Health and Medical Sciences, past-president of the Asia Pacific Society of Travel Medicine, recent Board Member for the International Society of Travel Medicine, Associate Editor for the Journal of Travel Medicine and Infectious Diseases, a Regional Advisor for the Journal of Travel Medicine, and an advisor to the Australian Spleen Registry. She serves on the Executive for the School of Public Health and Preventive Medicine at Monash University and is a leader for Monash’s Centre to Impact Antimicrobial Resistance (AMR). She has served on the NHMRC Research Translation Faculty for New and Emerging Health Threats Steering Group, the NHMRC Joint Steering Committee for National Guidelines on Water Recycling, the NHMRC Water Quality Advisory Committee and the NHMRC Training Awards Committee. She has been a Scientific Chair at multiple international travel medicine conferences. In 2018 she won the Frank Fenner award from the Australasian Society of Infectious Diseases.
Prof Leder is a member of the executive team for the Monash-led five-year RISE project (https://www.rise-program.org/) that will investigate the impact of improved environmental health on human health outcomes in informal communities. The project will provide sustainable water and sewage management to 24 slums in Fiji and Indonesia, and will investigate impacts on the physical and microbiological health of the environment and inhabitants. She is also CIA on an IDEAS grant (2020-2024) assessing the relative importance of pathogen acquisition by a range of exposure pathways. She has also led work examining the health effects of rainwater consumption, and her group is a leading resource for industry and government agencies for issues related to water and health.
Prof Leder has a Leadership role in and is the Australian GeoSentinel site director for the largest global sentinel surveillance system for imported infections. She has led or contributed to multiple collaborative internationally renowned research projects using these data, with outputs used to update international WHO and CDC guidelines for travel medicine. She has regularly contributed as an expert consultant for the WHO in International Travel and Health, and was an invited expert for WHO’s priority pathogens list.
Prof Leder has extensive experience with student supervision, mentoring and teaching, and runs courses on Infectious Disease Epidemiology for Monash’s Masters of Public Health. She has also played a key role in the Australian COVID response, including as a leading contributor to Australian National COVID-19 Clinical Evidence Taskforce, as an author of the Roadmap to Recovery report submitted to Government, via international collaborations to monitor spread of SARS-CoV-2 across international borders, and via a secondment to the Victorian Department of Health and Human Services to assist with their outbreak response.
Karin is a founding member of the Monash Centre to Impact AMR and is developing our AMR strategy within the Asia-Pacific region.
Annelies Wilder-Smith, MD, PhD, DTM&H, MIH, FAMS, FACTM
Professor of Infectious Diseases
London School of Hygiene and Tropical Medicine
Professor Annelies Wilder-Smith is Full Professor with Tenure for Infectious Diseases Research at Lee Kong Chian School of Medicine (LKCMedicine) which she joined in May 2013. Since July 2017, she only maintains a part-time position at LKC, as she is working as Consultant for Arboviral Diseases at the World Health Organization (WHO) in Geneva, Switzerland. At the Initiative for Vaccine Research (IVR) at WHO, her tasks are to deal with the WHO response to the safety issues of the first licensed dengue vaccine, coordinating research on the use of fractional dose of the yellow fever vaccine, and developing a Zika vaccine roadmap.
Aluisio Segurado, MD, PhD
President, University of Sao Paulo, Brazil
Professor of Infectious Diseases, Universidade de São Paulo Faculdade de Medicina: Sao Paulo, São Paulo, Brazil
Dr. Aluisio Segurado received his MD and PhD degrees from the University of São Paulo, where he is currently Full Professor of Infectious Diseases at the Faculty of Medicine. In the same institution he also acts as President of Hospital das Clinicas Central Institute Board and President of the International Relations Committee. Dr. Segurado has been involved in clinical studies related to infectious diseases and tropical medicine throughout his academic career and is currently conducting a cohort study to investigate the natural history and viral kinetics of ZIKV in Brazil as part of the ZikAlliance Research Consortium under the sponsorship of the European Commission. His research focuses on human retroviral infections (HIV/AIDS, HTLV) with particular interest on vulnerability to viral acquisition, disease progression and response to interventions.
Pornthep Chanthavanich, MD
Professor of Tropical Medicine
Mahidol University, Thailand
Pornthep Chanthavanich is an Associate Professor at the Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University. He graduated in medicine from Siriraj Medical School, Mahidol University. He holds postgraduate qualifications in DTM&H (Bangkok), MSc.MCH (London), DTCH (Liverpool), Dip. Thai Board of Pediatrics Infectious Diseases, Dip. Thai Board of Preventive Medicine (Travel Medicine). He was previously Head of the Department of Tropical Pediatrics, Deputy Director of Hospital for Tropical Diseases (Bangkok), and Deputy Dean of Faculty of Tropical Medicine, Mahidol University. He is now the President of Thai Society of Travel Medicine, Immediate Past President of Asia Pacific Travel Health Society, Secretary-General of Asian Society for Pediatric Infectious Diseases, Treasurer of International Society of Tropical Pediatrics. His research interests have been in travel medicine, vaccines, tropical medicine, and infectious diseases.